DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Mancuso ME, Callaghan MU, Kruse-Jarres R. et al.
Emicizumab prophylaxis in adolescent/adult patients with hemophilia A previously receiving episodic or prophylactic bypassing agent treatment: updated analyses from the HAVEN 1 study.
Blood 2017;
130 (Suppl. 01) 1071-1071
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.